Roche
Doing Now What Patients Need Next
About Roche
Funding & Growth
✓ Pros
- • Combined pharma and diagnostics strength
- • Genentech subsidiary for US pharma
- • Leader in personalized healthcare
- • Strong scientific culture
- • Good work-life balance
✗ Cons
- • Swiss headquarters (timezone)
- • Large company bureaucracy
- • Some overlap with Genentech
- • Complex matrix organization
🏢 Working Here
Roche's computational biology operations span multiple global sites - Basel (Switzerland), South San Francisco (Genentech), and Penzberg (Germany).
As the world's largest biotech company, Roche offers unparalleled scale in pharmaceuticals and diagnostics.
Bioinformaticians work across Roche Pharma Research (RRED), Roche Diagnostics, and Genentech (wholly owned subsidiary).
Teams focus on personalized healthcare, combining diagnostic tests with targeted therapies.
The culture is highly international with scientists from 100+ countries.
Work involves analyzing clinical trial genomics, developing companion diagnostics, and pioneering precision medicine approaches.
Roche's Basel headquarters offers exceptional quality of life in Switzerland, while US operations in South San Francisco provide Bay Area biotech ecosystem access.
The company's integration of pharma and diagnostics creates unique opportunities for computational biologists to see their work impact patient care from diagnosis through treatment.
🧬 Bioinformatics Focus
Roche's computational biology spans pharma research and diagnostics innovation. Key areas:
- Personalized healthcare - developing companion diagnostics for targeted therapies like Herceptin (breast cancer), Tecentriq (immunotherapy),
- Single - cell and spatial genomics - partnership with 10x Genomics, internal Roche platforms,
- Clinical genomics - analyzing biomarkers from Phase I-IV trials across oncology, neuroscience, rare diseases,
- Foundation Medicine integration - comprehensive genomic profiling for cancer patients (Roche acquired Foundation Medicine),
- Digital pathology and AI - analyzing tissue images for tumor characterization. Notable programs include FoundationOne CDx (companion diagnostic), ventana digital pathology, and NAVIFY tumor board platform. Technical challenges include integrating multi-modal data (genomics, imaging, clinical), developing robust biomarkers for regulatory approval, and scaling personalized medicine globally. The diagnostics + pharma combination allows computational biologists to work on the full patient journey from early detection to treatment response monitoring.
📈 Career Growth & Development
Career Paths
Scientist Track
Management Track
Compensation
Competitive base salaries are offered, along with performance bonuses (15-25% at senior levels) and stock appreciation rights.
Development
Roche invests heavily in employee development through internal training academies, external coursework, and international rotations.
Mobility
Unique opportunities exist to rotate between Roche sites in Basel, Genentech in South San Francisco, and other global locations.
Network
The Roche/Genentech combined network provides extraordinary alumni connections across the global pharmaceutical industry.
Expertise
Computational biologists can gain experience in both drug development and diagnostics, a rare and highly valued combination.
Culture
Roche values both deep technical expertise and cross-functional leadership.